£76.63

Springer Practical Pharmacology for Alzheimer’s Disease

Price data last checked 10 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 2 months ago.

£77 today · all-time low £76 (May 2026) · usually £76

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 81 days · 81 data points (no recent data)

Historical
Generating forecast…
£77.23 £76.35 £76.54 £76.73 £76.93 £77.12 £77.31 25 April 2026 15 May 2026 04 June 2026 24 June 2026 14 July 2026

Price Distribution

Price distribution over 81 days • 2 price levels

Days at Price
Current Price
75 days · current 6 days 0 19 38 56 75 £76 £77 Days at Price

Price Analysis

Most common price: £76 (75 days, 92.6%)

Price range: £76 - £77

Price levels: 2 different prices over 81 days

Description

In this book, the four leading experts on the ACE inhibitors donepezil, galantamine, and rivastigmine and the NMDA receptor antagonist memantine explain the practical pharmacology of these symptomatic drugs with the aim of providing a sound basis for their clinical use in patients with Alzheimer’s disease. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer’s disease and the book closes with an overview of the ways in which symptomatic drugs for dementia are used. The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer’s disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. The failure of clinical trials of these drugs to yield satisfactory results has, however, meant that for the time being patients continue to be treated only with symptomatic drugs. There is accordingly a need to become more proficient in the use of symptomatic medicines, and it is against the background of this quest that Practical Pharmacology for Alzheimer’s Disease will be of wide interest.   Review “Written by four experts in dementia research, this book describes the pharmacology of the four symptomatic drugs used in the treatment of Alzheimer's disease. It provides an overview of the basic theories of the pharmacology of Alzheimer's disease and the way in which the medications are used for the treatment of dementia. … book is most suitable for geriatric psychiatrists, geriatric medicine specialists, and neurologists who spend a significant amount of time treating people with Alzheimer's disease and other dementias.” (Danielle L. Anderson, Doody's Book Reviews, June, 2016) From the Back Cover The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer’s disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. However, the fact that clinical trials of these drugs have not yet yielded satisfactory results has meant that for the time being patients continue to be treated only with symptomatic drugs. Currently, four such drugs are available: donepezil, galantamine, rivastigmine, and memantine. In this book, the four leading experts on each of these drugs explain their practical pharmacology with the aim of providing a sound basis for their use, which to date has been of questionable proficiency. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer’s disease and the book closes with an overview of the ways in which symptomatic drugs are used for dementia. About the Author Dr. Takashi Kudo, Osaka University Health Care Center, Department of Psychiatry,Toyonaka, Japan Dr. Kenneth Davis, Mount Sinai Medical Center, New York, NY 10029, USA Dr. Rafael Blesa Gonzalez, Autonomous University of Barcelona, Barcelona, Spain Dr. David George Wilkinson, University of Southampton, Southampton, United Kingdom

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
19 February 2016
Listed Since
24 September 2015

Barcode

No barcode data available

Similar Products You Might Like

Practical Pharmacology for Alzheimer’s Disease
99% match

Practical Pharmacology for Alzheimer’s Disease

Springer

£145.35 14 Jul 2026
Research Progress in Alzheimer's Disease and Dementia, Volume 2: v. 2
97% match

Research Progress in Alzheimer's Disease and Dementia, Volume 2: v. 2

£69.64 09 Jul 2026
Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics
96% match

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics

Springer

£82.10 05 Jul 2026
Neuroprotection in Alzheimer's Disease
96% match

Neuroprotection in Alzheimer's Disease

Academic Press

£88.59 10 Jul 2026
Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4
96% match

Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4

£11.43 04 Jul 2026
Diagnosis and Management in Dementia: The Neuroscience of Dementia, Volume 1
96% match

Diagnosis and Management in Dementia: The Neuroscience of Dementia, Volume 1

Academic Press

£129.66 13 Jul 2026
Dementia: 3 (NIP- Neurology in Practice)
96% match

Dementia: 3 (NIP- Neurology in Practice)

Wiley-Blackwell

£54.20 06 Jul 2026
Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations
96% match

Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations

Wiley

£179.95 27 Jun 2026
A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment
96% match

A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment

Academic Press

£114.19 21 Jun 2026
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges
96% match

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Academic Press

£90.48 03 Jul 2026
Young-Onset Dementias, An Issue of Psychiatric Clinics of North America (Volume 38-2) (The Clinics: Internal Medicine, Volume 38-2)
96% match

Young-Onset Dementias, An Issue of Psychiatric Clinics of North America (Volume 38-2) (The Clinics: Internal Medicine, Volume 38-2)

Elsevier

£55.48 29 Jun 2026
Diagnosis and Management of Dementia : A Manual for Memory Disorders Teams: A Manual for Memory Disorders Teams (Oxford Medical Publications)
96% match

Diagnosis and Management of Dementia : A Manual for Memory Disorders Teams: A Manual for Memory Disorders Teams (Oxford Medical Publications)

Oxford University Press

£83.00 08 Jul 2026
Handbook of Research on Innovations in the Diagnosis and Treatment of Dementia (Advances in Psychology, Mental Health, and Behavioral Studies)
96% match

Handbook of Research on Innovations in the Diagnosis and Treatment of Dementia (Advances in Psychology, Mental Health, and Behavioral Studies)

IGI Global

£203.21 17 Jun 2026
The Neuropsychology of Cortical Dementias (Contemporary Neuropsychology)
96% match

The Neuropsychology of Cortical Dementias (Contemporary Neuropsychology)

Springer Publishing Company

£76.80 07 Jul 2026
Better Living With Dementia: Implications for Individuals, Families, Communities, and Societies
96% match

Better Living With Dementia: Implications for Individuals, Families, Communities, and Societies

Academic Press

£60.99 12 Jul 2026
Dementias: Handbook of Clinical Neurology (Series Editors: Aminoff, Boller and Swaab): 89 (Handbook of Clinical Neurology)
96% match

Dementias: Handbook of Clinical Neurology (Series Editors: Aminoff, Boller and Swaab): 89 (Handbook of Clinical Neurology)

Elsevier

£143.29 26 Jun 2026
Case Studies in Dementia: Volume 2: Common and Uncommon Presentations (Case Studies in Neurology)
96% match

Case Studies in Dementia: Volume 2: Common and Uncommon Presentations (Case Studies in Neurology)

Cambridge University Press

£42.72 13 Jul 2026
Computational and Experimental Studies in Alzheimer's Disease
96% match

Computational and Experimental Studies in Alzheimer's Disease

CRC Press

£107.98 17 Jun 2026
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease
96% match

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Academic Press

£92.39 02 Jul 2026
Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)
96% match

Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)

Humana

£84.81 09 Jul 2026
Dementia: A Global Approach
96% match

Dementia: A Global Approach

Cambridge University Press

£73.88 04 Jul 2026
Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)
96% match

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

CRC Press

£87.80 09 Jul 2026
Case Studies in Dementia: Common And Uncommon Presentations (Case Studies in Neurology)
96% match

Case Studies in Dementia: Common And Uncommon Presentations (Case Studies in Neurology)

Cambridge University Press

£57.86 11 Jul 2026
Handbook of Neuropsychology, 2nd Edition: Aging and Dementia (Volume 6) (Handbook of Neuropsychology, Volume 6)
96% match

Handbook of Neuropsychology, 2nd Edition: Aging and Dementia (Volume 6) (Handbook of Neuropsychology, Volume 6)

Elsevier

£67.16 05 Jul 2026